Strand Therapeutics
Boston, United States · Founded 2017
- Headquarters
- Boston
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
About
Strand Therapeutics is a clinical-stage, Boston-based biotechnology company leading the genetic medicine revolution, founded in 2017 by MIT biological engineers Jake Becraft and Tasuku Kitada, who created the first mRNA programming language. The company has taken complex, programmable mRNA medicines from design through manufacturing to patients, building a pipeline of next-generation therapeutics for cancers and autoimmune disease. Strand's interdisciplinary team is now developing new delivery systems for tissues across the body so genetic medicines can reach more patients.
Summary
Strand Therapeutics is a Biotech company based in Boston, United States, founded in 2017.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.